Ophthalmic Devices Market

Publisher Grand View Research

Published Jan 16, 2026

Length 175 Pages

SKU # GV20873207

Description

Ophthalmic Devices Market Summary

The global ophthalmic devices market size was valued at USD 20.5 billion in 2025 and is projected to reach USD 39.1 billion by 2033, growing at a CAGR of 8.6% from 2026 to 2033. The growth of the market can be attributed to the rising prevalence of optical disorders, such as glaucoma, cataracts, diabetic retinopathy, and vitreoretinal disorders, coupled with technological advancements in ophthalmic surgical as well as diagnostic instruments required for these target applications.

Improved government initiatives to increase market base for visual impairment, thereby expanding the market for growth. For instance, in May 2024, the World Health Organization (WHO) initiated the SPECS 2030 program to assist countries in meeting the global eye care goal of a 40% increase in access to appropriate spectacles for people.

The growing geriatric population is increasing the demand for ophthalmic devices as they are more susceptible to age-related ophthalmic disorders. According to the National Institute of Aging (NIA), the geriatric population is expected to reach around 72 million by 2030. The increasing prevalence of diabetes and the incidence of diabetes-related blindness are predicted to fuel market growth. According to the World Health Organization (WHO), nearly 422 million people worldwide have diabetes, and the majority live in low and middle-income countries.

Increased screen time, has been associated with the onset and progression of various eye diseases, thus increasing the demand for eye examinations. For instance, in May 2024, Prevent Blindness, a non-profit volunteering organization focused on preventing blindness and preserving sight through public and professional education, community, and patient service programs, launched the “It Started with an Eye Exam” campaign to encourage consumers to provide their stories about how eye care positively impacts their health. This campaign was funded by Vitaris, Inc., a healthcare company that holistically bridges the gap between generic and branded medications to address global healthcare needs.

Technological advancements have enabled accurate diagnosis and improved treatment of ophthalmic disorders. Advancements in medications, diagnostic devices, laser technology, and surgical techniques have improved the handling of cataracts and macular degeneration, glaucoma, and dry eye disease.

Market players are also developing advanced products to meet the demand for these products. For instance, in April 2023, Bausch & Lomb announced the launch of ophthalmic viscosurgical devices in the United States. In March 2023, WaveFront Dynamics Inc. announced the commercial launch of its WaveDyn vision Analyzer. Such initiatives help increase awareness about eye diseases and the availability of diagnostic equipment.

Global Ophthalmic Devices Market Report Segmentation

This report forecasts country-level revenue growth and analyzes the latest industry trends and opportunities in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global ophthalmic devices market report based on product, application, end-use, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)

Optical Coherence Tomography Scanners

Fundus Camera

Perimeters/Visual Field Analyzers

Autorefractors and Keratometers

Ophthalmic Ultrasound Imaging Systems

Ophthalmic A-Scan Ultrasound

Ophthalmic B-Scan Ultrasound

Ophthalmic Ultrasound Biomicroscopes

Ophthalmic Pachymeters

Tonometers

Slit Lamps

Phoropters

Wavefront Aberrometers

Optical Biometry Systems

Ophthalmoscopes

Lensmeters

Corneal Topography Systems

Specular Microscopes

Retinoscopes

Application Outlook (Revenue, USD Million, 2021 - 2033)

Cataract

Vitreo Retinal Disorders

Glaucoma

Refractor Disorders

End-use Outlook (Revenue, USD Million, 2021 - 2033)

Hospitals and Eye Clinics

Academic and Research Laboratories

Others

Region Outlook (Revenue, USD Million, 2021 - 2033)

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Please note The report will be delivered in 2-3 business days upon order notification.

Chapter 1. Methodology and Scope: 1.1. Market Segmentation and Scope; 1.2. Segment Definitions; 1.2.1. Technology; 1.2.2. Application; 1.2.3. End Use; 1.2.4. Regional scope; 1.2.5. Estimates and forecasts timeline; 1.3. Research Methodology; 1.4. Information Procurement; 1.4.1. Purchased database; 1.4.2. GVR’s internal database; 1.4.3. Secondary sources; 1.4.4. Primary research; 1.4.5. Details of primary research; 1.4.5.1. Data for primary interviews in North America; 1.4.5.2. Data for primary interviews in Europe; 1.4.5.3. Data for primary interviews in Asia Pacific; 1.4.5.4. Data for primary interviews in Latin America; 1.4.5.5. Data for Primary interviews in MEA; 1.5. Information or Data Analysis; 1.5.1. Data analysis models; 1.6. Market Formulation & Validation; 1.7. Model Details; 1.7.1. Commodity flow analysis (Model 1); 1.7.2. Approach 1: Commodity flow approach; 1.7.3. Volume price analysis (Model 2); 1.7.4. Approach 2: Volume price analysis; 1.8. List of Secondary Sources; 1.9. List of Primary Sources; 1.10. Objectives
Chapter 2. Executive Summary: 2.1. Market Outlook; 2.2. Segment Outlook; 2.2.1. Technology outlook; 2.2.2. Application outlook; 2.2.3. End Use outlook; 2.3. Regional outlook; 2.4. Competitive Insights
Chapter 3. Medical Imaging Market Variables, Trends & Scope: 3.1. Market Lineage Outlook; 3.1.1. Parent Market Outlook; 3.1.2. Related/ancillary market outlook; 3.2. Market Dynamics; 3.2.1. Market Driver Analysis; 3.2.1.1. Growing prevalence of cancer and cardiac diseases; 3.2.1.2. Favorable government initiatives; 3.2.1.3. Trends of preventive healthcare and disease screening programs; 3.2.1.4. Strategic collaborations; 3.2.1.5. Technological advancements; 3.2.2. Market Restraint Analysis; 3.2.2.1. High cost of medical imaging equipment; 3.2.2.2. Increasing use of refurbished products; 3.2.2.3. Lack of regulations in developing countries; 3.2.2.4. Lack of trained radiologists; 3.3. Medical Imaging Market Analysis Tools; 3.3.1. Industry Analysis - Porter’s; 3.3.1.1. Bargaining power of suppliers; 3.3.1.2. Bargaining power of buyers; 3.3.1.3. Threat of substitutes; 3.3.1.4. Threat of new entrants; 3.3.1.5. Competitive rivalry; 3.3.2. PESTEL Analysis; 3.3.2.1. Political landscape; 3.3.2.2. Economic landscape; 3.3.2.3. Social landscape; 3.3.2.4. Technological landscape; 3.3.2.5. Environmental landscape; 3.3.2.6. Legal landscape
Chapter 4. Medical Imaging Market: Technology Estimates & Trend Analysis: 4.1. Segment Dashboard; 4.2. Medical Imaging Market: Technology Movement Analysis; 4.3. Medical Imaging Market by Technology Outlook (USD Million); 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following; 4.5. X-ray Devices; 4.5.1. X-ray Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 4.5.1.1. Radiography; 4.5.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.5.1.2. Fluoroscopy; 4.5.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.5.1.3. Mammography; 4.5.1.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.6. Ultrasound; 4.6.1. Ultrasound Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 4.6.1.1. Handheld; 4.6.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.6.1.2. Compact; 4.6.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.6.1.3. Cart/trolley; 4.6.1.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.7. Computed Tomography; 4.7.1. Computed Tomography Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 4.7.1.1. High end slice CT; 4.7.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.7.1.2. Mid end slice CT; 4.7.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.7.1.3. Low end slice CT; 4.7.1.3.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.7.1.4. Cone beam CT; 4.7.1.4.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.8. Magnetic Resonance Imaging; 4.8.1. Magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 4.8.1.1. Closed System; 4.8.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.8.1.2. Open System; 4.8.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.9. Nuclear Imaging; 4.9.1. Nuclear Imaging Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 4.9.1.1. SPECT; 4.9.1.1.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million); 4.9.1.2. PET; 4.9.1.2.1. Market estimates and forecasts, 2021 - 2033 (Revenue, USD Million)
Chapter 5. Medical Imaging Market: Application Estimates & Trend Analysis: 5.1. Segment Dashboard; 5.2. Medical Imaging Market: Application Movement Analysis; 5.3. Medical Imaging Market by Application Outlook (USD Million); 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following; 5.5. Cardiology; 5.5.1. Cardiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.6. Oncology; 5.6.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.7. Neurology; 5.7.1. Neurology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.8. Orthopedics; 5.8.1. Orthopedics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.9. Gastroenterology; 5.9.1. Gastroenterology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.10. Gynecology; 5.10.1. Gynecology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 5.11. Other Applications; 5.11.1. Other Applications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Medical Imaging Market: End-use Estimates & Trend Analysis: 6.1. Segment Dashboard; 6.2. Medical Imaging Market: End-use Movement Analysis; 6.3. Medical Imaging Market by End-use Outlook (USD Million); 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following; 6.5. Hospitals; 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 6.6. Diagnostic Imaging Centers; 6.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million); 6.7. Others; 6.7.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Medical Imaging Market: Regional Estimates & Trend Analysis: 7.1. Regional Dashboard; 7.2. Regional Medical Imaging Market movement analysis; 7.3. Medical Imaging Market: Regional Estimates & Trend Analysis by Technology & End-use; 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following; 7.5. North America; 7.5.1. North America Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5.2. U.S.; 7.5.2.1. Key Country Dynamics; 7.5.2.2. Competitive Scenario; 7.5.2.3. Regulatory Framework; 7.5.2.4. Reimbursement scenario; 7.5.2.5. U.S. Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.5.3. Canada; 7.5.3.1. Key Country Dynamics; 7.5.3.2. Competitive Scenario; 7.5.3.3. Regulatory Framework; 7.5.3.4. Reimbursement scenario; 7.5.3.5. Canada Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6. Europe; 7.6.1. Europe Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.2. UK; 7.6.2.1. Key Country Dynamics; 7.6.2.2. Competitive Scenario; 7.6.2.3. Regulatory Framework; 7.6.2.4. Reimbursement scenario; 7.6.2.5. UK Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.3. Germany; 7.6.3.1. Key Country Dynamics; 7.6.3.2. Competitive Scenario; 7.6.3.3. Regulatory Framework; 7.6.3.4. Reimbursement scenario; 7.6.3.5. Germany Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.4. France; 7.6.4.1. Key Country Dynamics; 7.6.4.2. Competitive Scenario; 7.6.4.3. Regulatory Framework; 7.6.4.4. Reimbursement scenario; 7.6.4.5. France Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.5. Italy; 7.6.5.1. Key Country Dynamics; 7.6.5.2. Competitive Scenario; 7.6.5.3. Regulatory Framework; 7.6.5.4. Reimbursement scenario; 7.6.5.5. Italy Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.6. Spain; 7.6.6.1. Key Country Dynamics; 7.6.6.2. Competitive Scenario; 7.6.6.3. Regulatory Framework; 7.6.6.4. Reimbursement scenario; 7.6.6.5. Spain Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.7. Denmark; 7.6.7.1. Key Country Dynamics; 7.6.7.2. Competitive Scenario; 7.6.7.3. Regulatory Framework; 7.6.7.4. Reimbursement scenario; 7.6.7.5. Denmark Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.8. Sweden; 7.6.8.1. Key Country Dynamics; 7.6.8.2. Competitive Scenario; 7.6.8.3. Regulatory Framework; 7.6.8.4. Reimbursement scenario; 7.6.8.5. Sweden Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.6.9. Norway; 7.6.9.1. Key Country Dynamics; 7.6.9.2. Competitive Scenario; 7.6.9.3. Regulatory Framework; 7.6.9.4. Reimbursement scenario; 7.6.9.5. Norway Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7. Asia Pacific; 7.7.1. Asia Pacific Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.2. Japan; 7.7.2.1. Key Country Dynamics; 7.7.2.2. Competitive Scenario; 7.7.2.3. Regulatory Framework; 7.7.2.4. Reimbursement scenario; 7.7.2.5. Japan Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.3. China; 7.7.3.1. Key Country Dynamics; 7.7.3.2. Competitive Scenario; 7.7.3.3. Regulatory Framework; 7.7.3.4. Reimbursement scenario; 7.7.3.5. China Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.4. India; 7.7.4.1. Key Country Dynamics; 7.7.4.2. Competitive Scenario; 7.7.4.3. Regulatory Framework; 7.7.4.4. Reimbursement scenario; 7.7.4.5. India Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.5. South Korea; 7.7.5.1. Key Country Dynamics; 7.7.5.2. Competitive Scenario; 7.7.5.3. Regulatory Framework; 7.7.5.4. Reimbursement scenario; 7.7.5.5. South Korea Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.6. Australia; 7.7.6.1. Key Country Dynamics; 7.7.6.2. Competitive Scenario; 7.7.6.3. Regulatory Framework; 7.7.6.4. Reimbursement scenario; 7.7.6.5. Australia Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.7.7. Thailand; 7.7.7.1. Key Country Dynamics; 7.7.7.2. Competitive Scenario; 7.7.7.3. Regulatory Framework; 7.7.7.4. Reimbursement scenario; 7.7.7.5. Thailand Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.8. Latin America; 7.8.1. Latin America Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.8.2. Brazil; 7.8.2.1. Key Country Dynamics; 7.8.2.2. Competitive Scenario; 7.8.2.3. Regulatory Framework; 7.8.2.4. Reimbursement scenario; 7.8.2.5. Brazil Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.8.3. Mexico; 7.8.3.1. Key Country Dynamics; 7.8.3.2. Competitive Scenario; 7.8.3.3. Regulatory Framework; 7.8.3.4. Reimbursement scenario; 7.8.3.5. Mexico Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.8.4. Argentina; 7.8.4.1. Key Country Dynamics; 7.8.4.2. Competitive Scenario; 7.8.4.3. Regulatory Framework; 7.8.4.4. Reimbursement scenario; 7.8.4.5. Argentina Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.9. Middle East & Africa; 7.9.1. Middle East & Africa Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.9.2. South Africa; 7.9.2.1. Key Country Dynamics; 7.9.2.2. Competitive Scenario; 7.9.2.3. Regulatory Framework; 7.9.2.4. Reimbursement scenario; 7.9.2.5. South Africa Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.9.3. Saudi Arabia; 7.9.3.1. Key Country Dynamics; 7.9.3.2. Competitive Scenario; 7.9.3.3. Regulatory Framework; 7.9.3.4. Reimbursement scenario; 7.9.3.5. Saudi Arabia Medical Imaging Market Estimates and Forecasts, 22021 - 2033 (USD Million); 7.9.4. UAE; 7.9.4.1. Key Country Dynamics; 7.9.4.2. Competitive Scenario; 7.9.4.3. Regulatory Framework; 7.9.4.4. Reimbursement scenario; 7.9.4.5. UAE Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million); 7.9.5. Kuwait; 7.9.5.1. Key Country Dynamics; 7.9.5.2. Competitive Scenario; 7.9.5.3. Regulatory Framework; 7.9.5.4. Reimbursement scenario; 7.9.5.5. Kuwait Medical Imaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape: 8.1. Market Participant Categorization; 8.2. Key Company Profiles; 8.2.1. Koninklijke Philips N.V.; 8.2.1.1. Company overview; 8.2.1.2. Financial performance; 8.2.1.3. Product benchmarking; 8.2.1.4. Strategic initiatives; 8.2.2. GE Healthcare; 8.2.2.1. Company overview; 8.2.2.2. Financial performance; 8.2.2.3. Product benchmarking; 8.2.2.4. Strategic initiatives; 8.2.3. Siemens Healthcare; 8.2.3.1. Company overview; 8.2.3.2. Financial performance; 8.2.3.3. Product benchmarking; 8.2.3.4. Strategic initiatives; 8.2.4. Canon Medical Systems; 8.2.4.1. Company overview; 8.2.4.2. Financial performance; 8.2.4.3. Product benchmarking; 8.2.4.4. Strategic initiatives; 8.2.5. Mindray Medical International; 8.2.5.1. Company overview; 8.2.5.2. Financial performance; 8.2.5.3. Product benchmarking; 8.2.5.4. Strategic initiatives; 8.2.6. Esaote; 8.2.6.1. Company overview; 8.2.6.2. Financial performance; 8.2.6.3. Product benchmarking; 8.2.6.4. Strategic initiatives; 8.2.7. Hologic, Inc; 8.2.7.1. Company overview; 8.2.7.2. Financial performance; 8.2.7.3. Product benchmarking; 8.2.7.4. Strategic initiatives; 8.2.8. Samsung Medison Co.Ltd; 8.2.8.1. Company overview; 8.2.8.2. Financial performance; 8.2.8.3. Product benchmarking; 8.2.8.4. Strategic initiatives; 8.2.9. Koning Corporation; 8.2.9.1. Company overview; 8.2.9.2. Financial performance; 8.2.9.3. Product benchmarking; 8.2.9.4. Strategic initiatives; 8.2.10. Perkin Elmer Inc.; 8.2.10.1. Company overview; 8.2.10.2. Financial performance; 8.2.10.3. Product benchmarking; 8.2.10.4. Strategic initiatives; 8.2.11. FUJIFILM VisualSonics Inc.; 8.2.11.1. Company overview; 8.2.11.2. Financial performance; 8.2.11.3. Product benchmarking; 8.2.11.4. Strategic initiatives; 8.2.12. Carestream Health; 8.2.12.1. Company overview; 8.2.12.2. Financial performance; 8.2.12.3. Product benchmarking; 8.2.12.4. Strategic initiatives; 8.2.13. Hitachi; 8.2.13.1. Company overview; 8.2.13.2. Financial performance; 8.2.13.3. Product benchmarking; 8.2.13.4. Strategic initiatives; 8.2.14. Konica Minolta; 8.2.14.1. Company overview; 8.2.14.2. Financial performance; 8.2.14.3. Product benchmarking; 8.2.14.4. Strategic initiatives; 8.2.15. Varex Imaging; 8.2.15.1. Company overview; 8.2.15.2. Financial performance; 8.2.15.3. Product benchmarking; 8.2.15.4. Strategic initiatives

Pricing

Currency Rates

Single User Email from Publisher $5,950
Multi User License Fulfilled by Publisher $6,950
Global Site License Email from Publisher $8,950

How Do Licenses Work?

Request A Sample

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now